Since 2008 the Swiss Transplant Cohort Study (STCS) prospectively enrols patients who receive a solid organ or hematopoetic stem cells in Switzerland. Standardized data collection containing demographic, psychosocial, clinical, laboratory, and treatment information, is performed by physicians and study nurses at time of transplant, at six months and then yearly thereafter. The STCS is supported by the Swiss National Science Foundation (SNF) and other research funds. More than 80 nested projects are performed in the framework of the STCS. In a collaborative effort with the Federal Office of Public Health, the cohort ensures compliance with the requirements of the Swiss law.
• Wojtowicz A, Lecompte TD, Bibert S, et al. PTX3 polymorphisms and aspergillosis– a step towards personalized risk stratification in transplant recipients? Clin Infect Dis 2015: in press.
• Wojtowicz A, Lecompte TD, Bibert S, et al. PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant. Clin Infect Dis 2015; 61(4): 619-22.
• Wojtowicz A, Gresnigt MS, Lecompte T, et al. IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation. J Infect Dis 2015; 211(10): 1646-57.
• Schmied L, Terszowski G, Gonzalez A, et al. Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes. Transplantation 2015.
• Manuel O, Wojtowicz A, Bibert S, et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 2015; 211(6): 906-14.
• Berger C, Bochud PY, Boggian K, et al. The swiss transplant cohort study: lessons from the first 6 years. Curr Infect Dis Rep 2015; 17(6): 486.
• Stern M, Hirsch H, Cusini A, et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation 2014; 98(9): 1013-8.
• Pison C, Magnan A, Botturi K, et al. Prediction of chronic lung allograft dysfunction: a systems medicine challenge. Eur Respir J 2014; 43(3): 689-93.
• Gonzalez A, Schmitter K, Hirsch HH, et al. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes Immun 2014; 15(7): 495-9.
• De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transpl Int 2014; 27(7): 657-66.
• Burkhalter H, Wirz-Justice A, Cajochen C, et al. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. Clin Transplant 2014; 28(1): 58-66.
• Bucheli E, Kralidis G, Boggian K, et al. Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study. Transpl Infect Dis 2014; 16(1): 26-36.
• Manuel O, Kralidis G, Mueller NJ, et al. Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2013; 13(9): 2402-10.
• Koller MT, van Delden C, Muller NJ, et al. Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol 2013; 28(4): 347-55.
• De Geest S, Burkhalter H, Berben L, et al. The Swiss Transplant Cohort Study's framework for assessing lifelong psychosocial factors in solid-organ transplants. Prog Transplant 2013; 23(3): 235-46.
• Burkhalter H, Wirz-Justice A, Cajochen C, et al. Validation of a single item to assess daytime sleepiness for the Swiss Transplant Cohort Study. Prog Transplant 2013; 23(3): 220-8.
• Berger C, Boggian K, Cusini A, et al. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant 2012; 17(6): 581-5.
Department of Infectious Disease and Hospital Epidemiology
Prof. Dr. Nicolas Müller
University hospital Zurich